(Q39423216)

11 September 2017

Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years (English)

1 reference

11 September 2017

0 references

1 reference

R E Gonsette

1

1 reference

PubMed ID

65452

11 September 2017

L Demonty

series ordinal

2

1 reference

PubMed ID

65452

11 September 2017

P Delmotte

series ordinal

3

1 reference

11 September 2017

1 February 1977

1 reference

11 September 2017

1 reference

11 September 2017

214

1 reference

11 September 2017

3

1 reference

11 September 2017

173-181

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00316148

11 September 2017

0 references

cites work

An Immunopathologic Component in Experimental Togavirus Encephalitis

1 reference

https://api.crossref.org/works/10.1007%2FBF00316148

Transformation of lymphocytes from patients with multiple sclerosis. Use of encephalitogen of human origin, with a report of a trial of immunosuppressive therapy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00316148

Immune status of patients with multiple sclerosis: Analysis of primary and established immune responses in 24 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00316148

Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00316148

Failure of antilymphocytic globulin therapy in chronic progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00316148

Intensive immunosuppression in the treatment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00316148

Evaluation of antithymocyte globulin in acute relapses of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00316148

Multiple sclerosis unaffected by azathioprine in pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00316148

Failure of basic protein therapy for multiple sclerosis

21 January 2018

1 reference

12 December 2020

Effect of 'maximum immune suppression' with thoracic duct drainage, ALG, azathioprine and cortisone in some neurological disorders

1 reference

12 December 2020

Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response

1 reference

12 December 2020

A preliminary evaluation of azathioprine (Imuran) in the treatment of multiple sclerosis

1 reference

12 December 2020

Immunodepressive therapy in neurology

1 reference

12 December 2020

Immunosuppressive agents in multiple sclerosis. Preliminary trials with Proresid

1 reference

12 December 2020

Critic study of multiple sclerosis treatment by chlorambucil and intraspinal corticotherapy. Apropos of 100 cases followed up from 2 to 9 years

1 reference

12 December 2020

Cyclophosphamide in multiple sclerosis

1 reference

12 December 2020

[Multiple sclerosis and the autoimmunization process. Treatment by antimitotics]

1 reference

12 December 2020

[Treatment of multiple sclerosis using immunosuppression. Critical discussion of results]

1 reference

12 December 2020

Treatment of multiple sclerosis with intraspinal antilymphocyte serum: theoretical bases; opportunities for utilization

1 reference

12 December 2020

Therapeutic trial of immunosuppressive agents in multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis: pilot therapeutic trial of immunosuppressants

1 reference

12 December 2020

Immunosuppressive therapy of multiple sclerosis. 1. Preliminary communication on the results of treatment with azathioprine and anti-lymphocytic globulin

1 reference

12 December 2020

[Electrophoretic study of the cerebrospinal fluid proteins in multiple sclerosis. II. Influence of immunosuppressive chemotherapy]

1 reference

12 December 2020

Immunosuppressive therapy in neurological diseases.

1 reference

12 December 2020

[Experiences with cytostatic agents in multiple sclerosis]

1 reference

12 December 2020

Prospects of an immunologic therapy of multiple sclerosis

1 reference

12 December 2020

Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone

1 reference

12 December 2020

[Treatment of multiple sclerosis (recent concepts)]

1 reference

12 December 2020

Combined therapeutic trial in multiple sclerosis: hydrocortisone hemisuccinate with cyclophosphamide or cytosine arabinoside

1 reference

12 December 2020

Therapeutic trial of Imuran (azathioprine) in multiple sclerosis

1 reference

12 December 2020

Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis

1 reference

12 December 2020

Long-term treatment of multiple sclerosis with azathioprine

1 reference

12 December 2020

Critique of experimental trials of therapy in multiple sclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00316148

1 reference

11 September 2017

1 reference

PubMed ID

65452